- Home
- TSE vs COYA Comparison
TSE vs COYA Comparison
Compare TSE & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSE
- COYA
- Stock Information
- Founded
- TSE 2010
- COYA 2020
- Country
- TSE United States
- COYA United States
- Employees
- TSE N/A
- COYA N/A
- Industry
- TSE Major Chemicals
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- TSE Industrials
- COYA Health Care
- Exchange
- TSE Nasdaq
- COYA Nasdaq
- Market Cap
- TSE 112.7M
- COYA 99.8M
- IPO Year
- TSE 2014
- COYA 2022
- Fundamental
- Price
- TSE $2.96
- COYA $6.67
- Analyst Decision
- TSE
- COYA Strong Buy
- Analyst Count
- TSE 0
- COYA 4
- Target Price
- TSE N/A
- COYA $16.50
- AVG Volume (30 Days)
- TSE 560.1K
- COYA 88.2K
- Earning Date
- TSE 08-06-2025
- COYA 08-11-2025
- Dividend Yield
- TSE 1.35%
- COYA N/A
- EPS Growth
- TSE N/A
- COYA N/A
- EPS
- TSE N/A
- COYA N/A
- Revenue
- TSE $3,394,000,000.00
- COYA $3,685,107.00
- Revenue This Year
- TSE $1.84
- COYA $21.49
- Revenue Next Year
- TSE $4.44
- COYA N/A
- P/E Ratio
- TSE N/A
- COYA N/A
- Revenue Growth
- TSE N/A
- COYA N/A
- 52 Week Low
- TSE $2.16
- COYA $4.65
- 52 Week High
- TSE $7.05
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- TSE 46.35
- COYA 65.20
- Support Level
- TSE $2.78
- COYA $5.66
- Resistance Level
- TSE $3.20
- COYA $6.07
- Average True Range (ATR)
- TSE 0.16
- COYA 0.32
- MACD
- TSE 0.01
- COYA 0.06
- Stochastic Oscillator
- TSE 43.06
- COYA 88.60
About TSE Trinseo PLC
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.